Samsara Therapeutics Company

Samsara Therapeutics, Inc. is an R&D-stage biopharmaceutical platform company aiming to discover, develop and commercialize therapeutics for the treatment of unmet medical needs and age-related diseases. Samsara's platform is a pipeline for the identification, chemical optimization, and in vivo validation of compounds that extend a healthy lifespan.

Last Funding Type: Series A
Funding Status: Early Stage Venture
Headquarters: Boston, Massachusetts, United States
Founded Date: 2018-01-01
Investor Type: Company
Last Funding Date: 2021
Total Funding: 13513498
Technology: Geroscience
Employee Number: 1-10
Number Of Exists: Seed
Estimated Revenue: $1M to $10M
Investors Number: 2
Industry: Pharmtech